CLOs on the Move

Barnabas Health

www.barnabashealth.org

 
Barnabas Health provides treatment and services for more than two million patients each year: 198,000 inpatients and Same Day Surgery patients; 452,000 Emergency Department patients; and 1.5 million outpatients; and delivers more than 18,300 babies annually. Our 18,200 employees, 4,600 physicians and 445 residents and interns are united in our mission to deliver the highest quality of care in the best possible environment. Among our nationally renowned services are: New Jersey’s only certified burn treatment facility, world-class cardiac surgery services for adults; the oldest, most experienced heart transplant program in New Jersey ranked by volume in the top 10 in ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Bosley

Bosley is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TDC Medical Inc

TDC Medical Inc is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Autism Family Center

Autism Family Center fulfills a critical need for a coordinated, multidisciplinary approach to treating Autistic Disorder by providing a full range of services including Applied Behavior Analysis (ABA). Because we view families as an integrated system and believe that the health of every member is vital for each member to thrive, Autism Family Center provides support services for the entire family. Our process is designed to ensure maximum learning, unity and happiness.

Foss

Foss is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Seattle, WA. To find more information about Foss, please visit www.fosscare.org

Nymox

NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.